期刊文献+

树突状细胞诱导的淋巴因子激活的杀伤细胞对肺癌细胞系A549的体外杀伤作用 被引量:6

Cytotoxic Activity of LAK Cells Induced by Dendritic Cells against Lung Cancer Cell Line A549 in Vitro
下载PDF
导出
摘要 目的:探讨负载肺癌抗原的树突状细胞(dendritic cells,DC)诱导淋巴因子激活的杀伤(LAK)细胞对肺癌细胞A549的杀伤作用。方法:采用肺癌患者外周血单个核细胞(PBMC)经rhGM-CSF、rhIL-4、rhTNF-a诱导和肿瘤冻融抗原刺激诱导获得的DC与LAK细胞按1:20比例共培养2d,获得Ag-DC-LAK细胞作效应细胞,分别用Ag-Dc-LAK、DC-LAK、Ag-LAK和LAK对肺癌细胞系A549细胞进行杀伤实验。结果:以30μg/mL蛋白的肿瘤抗原负载的DC其表型CD1a、CD80、CD86、HLA-DR均显著升高(P<0.05),高于单纯细胞因子诱导成熟的DCs表型,由其刺激增殖的LAK细胞对肺癌细胞A549杀伤率为(71±5)%,明显高于对照组(P<0.05)。结论:经肿瘤抗原刺激诱导成熟的DC可有效传递抗原,增加T细胞对肿瘤细胞的杀伤作用。 Objective:To investigate cytotoxic activity of LAK cells stimulated by dendritic cells (DCs) pulsed with lung cancer cell lysate (Ag) against lung cancer cell line A549 in vitro. Methods : DCs derived from the PBMC of lung cancer patients were induced by combination of GM-CSF,IL-4 ,TNF-a and pulsed with tumour freeze-thaw antigen,which had been cultured with LAK cell at ratio 1: 20 for 2 d( Ag-DC- LAK) ,and then these cultured cells were used to kill the A549 cell line cells in vitro. Ag-LAK, DC-LAK, LAK served as control group. Results:The cultured Ag-DC expressed by CD1a, CD80, CD86, HLA-DR were significantly higher than that of simple DC group( P 〈 0.05 ). The killing rate of Ag-DC-LAK to the lung cancer cell line A549 was (71 +5)% ; the rates in the groups of Ag-DC-LAK were significantly higher than that of the control group ( P 〈 0.05 ). Conclusion : Dendritic cells ( DCs ) pulsed with lung cancer cell lysate (Ag) can enhance cytotoxic activity of LAK cells to cancer cells in vitro.
机构地区 解放军
出处 《华北国防医药》 2009年第6期11-12,F0002,共3页 Medical Journal of Beijing Military Region
关键词 树突状细胞 杀伤细胞 淋巴因子激活 肺癌 免疫疗法 Dendritic cells Killer cells, lymphokine-activated Lung cancer Immunotherapy
  • 相关文献

参考文献6

  • 1Gutcher I, Becher B. APC-derivde cytokines and T cell polarization in autoimmune in flammation [ J ]. J Clin Invest, 2007,117(5) :1119-1127. 被引量:1
  • 2Lutz M B,Kukutsch N, Ogilvie A L,et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow [ J ]. J Immunol Methods, 1999,223 ( 1 ) :77-92. 被引量:1
  • 3郭智,张波,阮新建,楼金星,何学鹏,谭晓华.树突状细胞与细胞因子诱导的杀伤细胞治疗急性白血病效果观察[J].华北国防医药,2007,19(2):13-15. 被引量:4
  • 4刘畅,谭晓华,刘端祺.树突状细胞与肿瘤免疫治疗的现状[J].华北国防医药,2005,17(5):315-318. 被引量:2
  • 5Reinhard G, Marten A, Kiske S M, et al. Generation of dendritic cell-based vaccines for cancer therapy[ J]. Br J Cancer,2002,86(10) :1529-1533. 被引量:1
  • 6Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations [ J ]. J immunother, 2001,24 (6) :502-510. 被引量:1

二级参考文献34

  • 1于哲,范清宇.树突状细胞肿瘤疫苗的研究进展[J].医学研究生学报,2005,18(1):63-66. 被引量:8
  • 2郭智,谭晓华,高锦,楼金星,刘晓东,何学鹏.CIK治疗耐药性非霍奇金淋巴瘤疗效观察[J].实用癌症杂志,2006,21(1):15-16. 被引量:29
  • 3Schadendorf D, Paschen A, Sun Y, et al. Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma[ J]. Immunol Lett ,2000,74:67-74. 被引量:1
  • 4Banchereau J, Steinman RM. Dendritic cells and the control of immunity[ J]. Nature, 1998,392:245-252. 被引量:1
  • 5张锦,陈慎仁,主编.树突状细胞与肿瘤免疫治疗[M].汕头:汕头大学出版社,2001.202-215. 被引量:1
  • 6Morse MA,Lyerly HK. Dendritic cell-based immunization for cancer therapy[J]. Adv Exp Med Biol,2000,465:335-346. 被引量:1
  • 7Chen SR, Akbar SM, Tanimoto K, et al. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma:relevance to hepatocarcinogenesis [ J ]. Cancer Lett, 2000,148: 49 -57. 被引量:1
  • 8Almand B, Resser JR, Lindman B, et al. Clinical significance of defective dendritic cell differentiation in cancer [ J ]. Clin Cancer Res ,2000,6:1755-1766. 被引量:1
  • 9Troy AJ, Davidson PJ, Atkinson CH, et al. CD1 a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated [ J ]. J Urol, 1999,161:1962-1967. 被引量:1
  • 10Mailliard RB, Dallal RM, Son YI, et al. Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen [ J ]. Immunol Invest, 2000,29,177-185. 被引量:1

共引文献4

同被引文献60

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部